Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 26, 2026

Mar. 26, 2026

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

GlobeNewswire

Mar. 26, 2026

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 26, 2026

Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 26, 2026

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 26, 2026

NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

GlobeNewswire

Mar. 26, 2026

NANOBIOTIX publiera ses résultats financiers et opérationnels de l’exercice 2025 le 31 mars 2026

GlobeNewswire

Mar. 26, 2026

ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions Awards

GlobeNewswire

Mar. 26, 2026

SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

GlobeNewswire

Mar. 26, 2026

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

GlobeNewswire

Mar. 26, 2026

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 26, 2026

Rapid7 Acquires Kenzo Security to Accelerate Preemptive, AI-Powered Security Operations

GlobeNewswire

Mar. 26, 2026

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

GlobeNewswire

Mar. 26, 2026

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 26, 2026

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

GlobeNewswire

Mar. 26, 2026

Datacentrex Announces Proposed Public Offering

GlobeNewswire

Mar. 26, 2026

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

GlobeNewswire

Mar. 26, 2026

CEA Industries Provides Update on Status of Renegotiation of Asset Management Agreement with 10X Capital

GlobeNewswire

Mar. 26, 2026

Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates

GlobeNewswire

Mar. 26, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

GlobeNewswire

Mar. 26, 2026

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

GlobeNewswire